Complications after BCG immunotherapy - neither a mountain nor a molehill Re: Bladder health in patients treated with BCG instillations for T1G2-G3 bladder cancer - a follow-up five years after the start of treatment

被引：0

作者：

Krajewski, Wojciech ^{[1
]}

Poletajew, Slawomir ^{[2
]}

Zdrojowy, Romuald ^{[1
]}

Kolodziej, Anna ^{[1
]}

机构：

[1] Wroclaw Med Univ, Dept Urol & Oncol Urol, Wroclaw, Poland

[2] Med Univ Warsaw, Dept Gen Oncol & Funct Urol, Warsaw, Poland

来源：

SCANDINAVIAN JOURNAL OF UROLOGY | 2019年 / 53卷 / 04期

关键词：

D O I：

10.1080/21681805.2019.1617775

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：265 / 266

页数：2

共 3 条

[1] Side Effects of Bacillus Calmette-Guerin (BCG) in the Treatment of Intermediate- and High-risk Ta, T1 Papillary Carcinoma of the Bladder: Results of the EORTC Genito-Urinary Cancers Group Randomised Phase 3 Study Comparing One-third Dose with Full Dose and 1 Year with 3 Years of Maintenance BCG [J].

Brausi, Maurizio ;

Oddens, Jorg ;

Sylvester, Richard ;

Bono, Aldo ;

van de Beek, Cees ;

van Andel, George ;

Gontero, Paolo ;

Turkeri, Levent ;

Marreaud, Sandrine ;

Collette, Sandra ;

Oosterlinck, Willem .

EUROPEAN UROLOGY, 2014, 65 (01) :69-76

[2] Bladder health in patients treated with BCG instillations for T1G2-G3 bladder cancer - a follow-up five years after the start of treatment [J].

Danielsson, Gun ;

Malmstrom, Per-Uno ;

Jahnson, Staffan ;

Wijkstrom, Hans ;

Nyberg, Tommy ;

Thulin, Helena .

SCANDINAVIAN JOURNAL OF UROLOGY, 2018, 52 (5-6) :377-384

[3] Are There Differences in Toxicity and Efficacy between Various Bacillus Calmette-Guerin Strains in Bladder Cancer Patients? Analysis of 844 Patients [J].

Krajewski, Wojciech ;

Matuszewski, Michal ;

Poletajew, Slawomir ;

Grzegrzolka, Jedrzej ;

Zdrojowy, Romuald ;

Kolodziej, Anna .

UROLOGIA INTERNATIONALIS, 2018, 101 (03) :277-284

← 1 →